Skip to main content
. 2021 Dec 3;9(5):1290–1300. doi: 10.1016/j.gendis.2021.11.007

Figure 3.

Fig. 3

The RBD specific monoclonal antibodies (mAbs) against pseudoviruses. (A) The half-maximal inhibitory concentrations (IC50) representative neutralization curves for tested anti-RBD (receptor-binding domain) monoclonal antibodies (mAbs) against D614G, B.1.1.7 and B.1.617 pseudoviruses. Pseudotypes were incubated with different mAbs dilutions for 60 min at 37 °C, and then were incubated onto 293T-ACE2 cells. Upon 72 h, cells were lysed with passive lysis buffer and the activity of firefly luciferase was analyzed. (B) The IC50 and IC80 were quantitatively analyzed using Graphpad 8.0.